You really don't know much. Some patients on Pro 140 approaching 2 years on P 2b extension study, on monotherapy with excellent results. And , no, no one need two Phase 3 study. One Phase 3 is enough .
You do realize that the company is running both adjunct therapy -- combination and monotherapy right? That's two different phase 3 trials...... sigh for you.